Skip to main content
. 2023 Feb 25;14:26. doi: 10.4103/ijpvm.ijpvm_356_21

Table 3.

The comparison between low- and high-risk groups based on SBQ

Variables Low-Risk Group Moderate-to-Severe-Risk Group P
Sex, n (%)
 Female 116 (81.7) 53 (45.3) <0.001
 Male 26 (18.3) 64 (54.7)
Age (years), mean±SD 38.74±16.43 59.12±13.96 <0.001
Diseases, n (%) <0.001
 No disease 93 (65.5) 32 (27.8)
 Other chronic diseases 49 (34.5) 83 (72.2)
BMI (kg/m2), mean±SD 24.81±4.35 29.08±5.37 <0.001
Neck size, n (%) <0.001
 Less than 40 cm 129 (90.8) 72 (61.5)
 More than 40 cm 13 (9.2) 45 (38.5)
Types of DM, n (%) <0.001
 T1DM 85 (59.9) 15 (12.8)
 T2DM 57 (40.1) 102 (87.2)
BQ status, mean±SD <0.001
 Low risk 126 (88.7) 33 (28.2)
 High risk 16 (11.3) 84 (71.8)
Medications, mean±SD <0.001
 Oral agent 44 (31) 75 (64.1)
 Insulin 98 (69) 42 (35.9)
FBS, mean±SD 137.20±49.47 153.81±61.63 0.019
HbA1c, mean±SD 7.48±1.52 7.89±1.74 0.046
HbA1c status, mean±SD 0.110
 Poor control 73 (51.8) 48 (41.7)
 Good control 68 (48.2) 67 (58.3)